|From||DUIP Inquiries (CDC) email@example.com details|
|Good morning Lana,
Thank you very much for your email; we do appreciate your comments. CDC has prioritized the development of this guideline in order to improve pain treatment and help prevent those suffering from pain from experiencing addiction and/or overdose. The guideline is not a regulation or law, but rather a set of recommendations for primary care providers. The recommendations in the Guideline are voluntary, and are intended to support informed clinical decision making in the context of the provider-patient relationship. Patient safety is our top concern, andCDC encourages providers and patients to carefully consider both the benefits and serious risks of these medications in making decisions about chronic pain management. The Guideline is not intended to take away physician discretion and decision-making, but it is designed to help physicians assess how to safely maintain or discontinue opioid use in patients who are currently on an opioid treatment plan or start opioids safely if necessary. Specifically, the Guideline includes a recommendation to taper or reduce dosage only when patient harm outweighs patient benefit of opioid therapy.
For more information on the specific guideline recommendations, please visit http://www.cdc.gov/drugoverdose/prescribing/guideline.html.
Division of Unintentional Injury Prevention
|DUIP Inquiries (CDC) firstname.lastname@example.org details|